Dougherty Wealth Advisers’s Gilead Sciences GILD Stock Holding History

Dougherty Wealth Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,031	Closed	-$60K	–	137
2020 Q4	$60K	Hold	1,031	–	–	0.09%	91
2020 Q3	$65K	Hold	1,031	–	–	0.22%	80
2020 Q2	$79K	Hold	1,031	–	–	0.29%	67
2020 Q1	$77K	Hold	1,031	–	–	0.31%	63
2019 Q4	$67K	Hold	1,031	–	–	0.2%	87
2019 Q3	$65K	Hold	1,031	–	–	0.21%	84
2019 Q2	$70K	Hold	1,031	–	–	0.2%	92
2019 Q1	$67K	Hold	1,031	–	–	0.23%	81
2018 Q4	$69K	Buy	+1,031	New	+$72.1K	0.23%	80

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dougherty Wealth Advisers's GILD Position: Q1 2021 in Review

Dougherty Wealth Advisers sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 1,031 shares — an estimated $60K sold.

Dougherty Wealth Advisers first reported a position in GILD in Q4 2018 and held it in 9 quarters. The position peaked at $79K in Q2 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

Dougherty Wealth Advisers reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
Dougherty Wealth Advisers sold 1,031 Gilead Sciences shares in Q1 2021, an estimated $60K.
Dougherty Wealth Advisers first reported a position in Gilead Sciences in Q4 2018 and held it in 9 quarters.
Dougherty Wealth Advisers's Gilead Sciences position peaked at $79K in Q2 2020.
1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Dougherty Wealth Advisers's 13F filing for Q1 2021, filed 6 May 2021.